Anca Askanase, MD, MPH
Director
Columbia University Medical Center
New York, NY, United States
Disclosure(s): Amgen: Advisor or Review Panel Member (Ongoing); AstraZeneca: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing); Aurinia: Advisor or Review Panel Member (Ongoing); Eli Lilly: Grant/Research Support (Ongoing); GlaxoSmithKlein(GSK): Advisor or Review Panel Member (Ongoing); Idorsia: Grant/Research Support (Ongoing); Janssen: Grant/Research Support (Ongoing); Pfizer: Grant/Research Support (Ongoing); UCB: Grant/Research Support (Ongoing)
This session explains the pathophysiology of SLE and potential pathways for therapeutic targets.
Developed and offered by GSK